[Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions]

Standard

[Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions]. / Helpap, B; Köllermann, Jens.

In: PATHOLOGE, Vol. 21, No. 3, 3, 2000, p. 211-217.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{c6a4454252be4f7fbd83bad59bd4cddc,
title = "[Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions]",
abstract = "Recently the World Health Organization published a new classification of urinary bladder tumors which is intended to take into account better the biology of the various lesions and to better distinguish between clearly benign and malignant lesions. We examine the possible diagnostic and clinical impact of the new classification, including recent immunohistochemical findings. Papillary urothelial lesions include papillomas, papillary neoplasms of low malignant potential, and papillary carcinomas. Flat urothelial lesions include hyperplasia, reactive atypia/atypia of unknown significance, dysplasia, and carcinoma in situ. Invasive patterns of papillary carcinomas are discussed, with special emphasis on lamina muscularis mucosae substaging. The most important feature of the new classification is its differentiation of two types of low-grade, noninvasive papillary urothelial lesions: papillary neoplasm of low malignant potential vs. papillary carcinoma. Long-term follow-up studies are needed to determine the clinical significance of this differentiation.",
author = "B Helpap and Jens K{\"o}llermann",
year = "2000",
language = "Deutsch",
volume = "21",
pages = "211--217",
journal = "PATHOLOGE",
issn = "0172-8113",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - [Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions]

AU - Helpap, B

AU - Köllermann, Jens

PY - 2000

Y1 - 2000

N2 - Recently the World Health Organization published a new classification of urinary bladder tumors which is intended to take into account better the biology of the various lesions and to better distinguish between clearly benign and malignant lesions. We examine the possible diagnostic and clinical impact of the new classification, including recent immunohistochemical findings. Papillary urothelial lesions include papillomas, papillary neoplasms of low malignant potential, and papillary carcinomas. Flat urothelial lesions include hyperplasia, reactive atypia/atypia of unknown significance, dysplasia, and carcinoma in situ. Invasive patterns of papillary carcinomas are discussed, with special emphasis on lamina muscularis mucosae substaging. The most important feature of the new classification is its differentiation of two types of low-grade, noninvasive papillary urothelial lesions: papillary neoplasm of low malignant potential vs. papillary carcinoma. Long-term follow-up studies are needed to determine the clinical significance of this differentiation.

AB - Recently the World Health Organization published a new classification of urinary bladder tumors which is intended to take into account better the biology of the various lesions and to better distinguish between clearly benign and malignant lesions. We examine the possible diagnostic and clinical impact of the new classification, including recent immunohistochemical findings. Papillary urothelial lesions include papillomas, papillary neoplasms of low malignant potential, and papillary carcinomas. Flat urothelial lesions include hyperplasia, reactive atypia/atypia of unknown significance, dysplasia, and carcinoma in situ. Invasive patterns of papillary carcinomas are discussed, with special emphasis on lamina muscularis mucosae substaging. The most important feature of the new classification is its differentiation of two types of low-grade, noninvasive papillary urothelial lesions: papillary neoplasm of low malignant potential vs. papillary carcinoma. Long-term follow-up studies are needed to determine the clinical significance of this differentiation.

M3 - SCORING: Zeitschriftenaufsatz

VL - 21

SP - 211

EP - 217

JO - PATHOLOGE

JF - PATHOLOGE

SN - 0172-8113

IS - 3

M1 - 3

ER -